Brad Stanfield: The Mold That Saved 100 Million Lives
Peer-Reviewed Research
Key Takeaways
- Statin therapy is one of the most effective interventions for preventing heart attacks, with overwhelming evidence supporting its use.
- Most reported statin side effects (e.g., muscle pain) are due to the nocebo effect, not the drug itself, as shown in blinded trials like the SAMSON trial.
- Statin use is associated with a modest (9%) increased risk of type 2 diabetes but also a 14% lower risk of dementia.
- Avoid stopping statin medication based on unverified claims online; consult your doctor if you have concerns.
Products & Gear Mentioned
- The Cholesterol Myths by Uffe Ravnskov
Notable Quotes
“The millions of people whose lives will be extended through statin therapy owe it all to Akira Endo.” – Michael Brown and Joseph Goldstein
“90% of the symptom burden that these patients experienced on statins were triggered also by the placebo.” – SAMSON Trial
Bottom Line
Continue taking statin medication as prescribed unless advised otherwise by your doctor, as it significantly reduces heart attack risk with minimal side effects.
Shop the gear mentioned in this video
As an Amazon Associate, we earn from qualifying purchases.
Explore More
- Brad Stanfield’s Full Protocol — supplements, dosages, and daily routine
- Compare All Protocols — side-by-side protocols
Watch the Full Video
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. The research summaries presented here are based on published studies and should not be used as a substitute for professional medical consultation. Always consult a qualified healthcare provider before making any changes to your health regimen.
Peer-reviewed health research, simplified. Early access findings, clinical trial alerts & regulatory news — delivered weekly.
No spam. Unsubscribe anytime. Powered by Beehiiv.
Related Research
From Our Research Network
Daily longevity researchZone2 Training
Exercise protocolsSleep Science
Sleep optimization
Part of the Evidence-Based Research Network
